Additional mechanisms include amplification of the MET gene [11, 12, 14], PIK3CA mutation [11, 15], BRAF mutation [16], epithelial-to-mesenchymal transition (EMT) [11], and small cell lung cancer (SCLC) transformation [11, 12]. The gene discussed is PIK3CA; the disease is small cell lung carcinoma.